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ABSTRACT – Objective: To review the available 
evidence establishing the validity of adding   
electrocardiogram to the preparticipation cardiac 
screening in athletes. Data Sources: MEDLINE and 
CINAHL databases were searched. Additional references 
from the bibliographies of retrieved articles were also 
reviewed and experts in the area were contacted. 
Selection Criteria: Only original research articles 
seeking to establish the use of electrocardiography 
followed by second line investigations in athletes under 36 
years of age were reviewed. Search Result and Quality 
Assessment: The initial literature search identified 226 
papers. Of these, 16 original articles (all type II 
evidence—population-based clinical studies) met the 
selection criteria and directly related to the use of 
electrocardiography in athletes cardiac screening. The 
methodological qualities of included studies were 
assessed using the Downs and Black checklist. 
Conclusion: Screening with electrocardiography 
represents best clinical practice to prevent or reduce the 
risk of sudden cardiac death in athletes. It significantly 
improves the sensitivity of history and physical 
examination alone; it has reasonable specificity and 
excellent negative predictive value; and it is cost-effective. 
Future studies must be large, multicentre, multination, 
prospective trials powered to determine how different 
screening options affect the incidence of sudden cardiac  
 
 
death. Efforts should also be targeted toward secondary 
prevention of sudden cardiac death with pitch side 
cardiac resuscitation and the immediate use of 
defibrillator. 
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Sudden cardiac death (SCD) is the leading cause of 
mortality in young athletes during exercise, and it mainly 
results from undiagnosed structural or electrical 
cardiovascular disease [1, 2]. The incidence of SCD in 
young athletes varies widely from 0.5-2/100,000/year 
[3,4]. The best way to screen athletes for conditions 
predisposing them to sudden cardiac death is a topic of 
debate. In 2005 the European Society of Cardiology 
proposed a common European protocol for cardiovascular 
preparticipation screening of athletes for the prevention of 
the sudden cardiac death [5]; The success of the European 
model of preparticipation evaluation is mostly attributed 
to the inclusion of electrocardiography to basic screening 
protocol and its great ability to identify athletes at risk of 
sudden cardiac death due to some underlying cardiac 
abnormalities [6]. On the contrary, the American Heart 
Association does not endorse the routine use of 
electrocardiography for mass cardiac screening of athletes 
on the presumption of high false positive results [7] 
especially when the screening is merely used as a 
prevention of sudden death caused by rare and hereditary 
conditions [8]. 
This review offers an up to date perspective on the 
effectiveness of electrocardiography cardiac screening in 
athletes. The latest review was done in 2004 [9]. 
2 Methods 
2.1 Inclusion and exclusion criteria 
 
Inclusion criteria: (1) original published studies in 
English language in peer-review journals involving the 
use of electrocardiography in preparticipation evaluation 
of athletes; (2) must include second line investigation 
(echocardiography, stress ECG, 24 hours ECG etc.);      
(3) study population not restricted to gender, ethnicity or 
athletic level, yet age restricted to less than 36 years of 
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age; and (4) no restriction on study design. Studies were 
excluded if they involved non athletic population. 
 
2.2      Search strategy 
 
An electronic database search was performed using 
MEDLINE (1948 to present) and CINAHL Plus with 
Full-Text (1937 to present). A keyword search yielded 
MeSH/CINAHL headings, which were combined and 
exploded (Table 1). Searches were restricted to English 
language and human subjects. The list of references was 
downloaded into EndNote reference manager website, 
including MeSH headings and abstracts and duplicate 
references were removed. The bibliographies of the final 
articles selected were scanned to assure no articles were 
excluded. The relevant original articles relating 
specifically to the review question were retrieved. Experts 
in the area were contacted for relevant and even on-going 
research.  
 
Table 1 Search strategy and results from each included database 
 
 Key words Medline CINAHL 
1 Preparticipation 365 118 
2 Screening 220644 27987 
3 Athletes 18559 8797 
4 Electrocardiography 94951 8372 
5 Sudden, cardiac, death 5738 552 
6 Preparticipation AND athletes 
(both exploded) 
248 90 




8 Screening AND athletes (both 
exploded) 
708 214 








11 Athletes AND sudden cardiac 
death (both exploded) 
227 28 
12 6 AND electrocardiography 67 21 
13 8 AND electrocardiography 158 38 
14 11 AND electrocardiography 88 16 
 Subtotal  ( 12+13+14 ) 313 75 
 Duplicate  114 19 
 Total 199 56 
 Total Search after combining 
all database search and 
removal of duplicate 
                    226 
 
3 Result & Discussion 
3.1 Review selection and identification 
 
The search strategy retrieved 226 papers, of which 
188 were narrative reviews, technical notes and 
letters/personal opinion. A total of 38 relevant trials 
underwent further analysis for inclusion. 22 studies were 
excluded, of which four studies targeted senior athletes 
[10-13], nine looked at structural and electrophysiological 
remodelling of the athletes heart [14-22], five studies 
discussed the aetiology and management of sudden 
cardiac death [23-27], three studies were surveys 
examining methods of athletes screening [28-30], and one 
examined use of echocardiography in cardiac screening 
[31]. Consequently, 16 original articles met the selection 
criteria, and directly relating to the use of 
electrocardiography in athletes cardiac screening (Table 
2).  
Table 2: Characteristics of studies evaluating the use of ECG in Athletes preparticipation evaluation 
Reference Study Design Study Setting/Measures Conclusion 
Maron et al [29] Cross sectional 
 
501 Athletes from University of Maryland 
 
Hx, PE, and ECG compared to echo for 
evidence of CVD  
Specificity 27%, false positive 15% 
 
Poor sensitivity, no cases of lethal CVD 
found. ECG did not increase sensitivity of 
Hx/PE 





(2) Cross sectional 
Trend of SCD in athletes and nonathletic 
population (12-35yrs) in the Veneto region of 
Italy (period 1979-2004) 
 
Cardiovascular causes of sports disqualification 
in 42,386 athletes (period 1982-2004) 
Decreased annual SCD by 89% 
 
8.9% required further test (following ECG) 
 
2% were disqualified 
Fuller et al [31] Cohort 5615 high school student athletes. 
 
Compared ECG to Hx, PE (by cardiologists and 
blinded) echo and stress test done as indicated 
Specificity 97.8% for Hx/PE, 97.4% for 
ECG; ECG sensitivity 70%, false +ve rate 
2.6% 
 
ECG has similar specificity to Hx/PE yet 
more effective as screening tool for CVD 
Pelliccia et al [32] Cross sectional 1005 elite 
Italian athletes from 38 sports. 
 
ECG patterns compared with echo ( both 
interpreted blindly) 
Sensitivity 51%, specificity 61%, PPV 7%, 
NPV 96% ( for ECG detection) 
 
False positives caused by athletes heart 
limits ECG usefulness in PPE 
Basso et al [33] Retrospective case 
review 
2 large registries of SCD in young athletes in 
USA and Italy. 
 
ECG, stress test, echo for detecting AOCA 
27 cases of AOCA, age 9-32y, all had 
normal ECG, echo, stress test. 
 
Standard PPE limited in ability to detect 
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AOCA 
Baggish et al [34] Cross sectional  510 collegiate athletes 
 
H/o, PE, with and without ECG 
ECG improved sensitivity from 45.5% to 
90,9%; NPV from 98.7% to 99.8%; False 
+ve 16.9% 
 
Hevia et al [35] Cross sectional  1220 Spanish athletes from different sports 
disciplines 
 
H/o, PE, ECG and further tests 
3.7% required additional tests 
 
2 diagnosed (1 echo, 1 MRI) 
Magalski et al [36] Cohort  964 competitive collegiate athletes 
 
H/o, PE, ECG and Echo 
ECG improved sensitivity from 44.4% to 
88.9%; NPV from 99.3% to 99.9% 
Bessem et al [37] Cross sectional 825 athletes cardiac screening using the 
Lausanne recommendation (H/o, PE, ECG) 
 
University centre of sports medicine in 
Groningen, Netherland 
6.3% had additional test based on ECG 
ECG had 11% false positive rate 
 
Number needed to screen was 1:143 
Sofi et al [38] Cross sectional  30,065 participants in competitive sports at 
Institute of sports medicine in Florence , Italy 
 
H/o, PE, resting and stress ECG  
Abnormal finding: 
 
Resting ECG 6% 
Stress ECG 4.9% 
 
0.6% ineligible for competitive sports 
Tanaka et al [39] Prospective, 
cross sectional 
37,804 students with 6 years follow up part of 
national cardiac screening program in 
Kagoshima, Japan 
( included athletes and non-athletes) 
 
H/x, PE, ECG, and echo if needed  
3 SCD, one screened and diagnosed with 
HCM, 2 normal ECG findings 
 




Marek et al [40] Retrospective,  
cohort Study 
High school ECG screening program (YH4L) in 
Chicago, USA, 32,561 High school student 
 
H/o, PE, ECG 




Steinvil et al [41] Retrospective, cohort 
study 
Systematic search of 2 newspapers in 
Israel to determine number of SCD 
in competitive athletes. 
 
Israeli national mandatory PPE 
includes resting and stress ECG 
2.6 events per 100,000 person-years 
 
ECG had no apparent influence on 





Table 2 Continued 
Reference Study Design Study Settings/Measures Conclusion 
 
Wilson et al [42] Cross sectional 1074 national and international junior 
athletes and 1646 physical active 
schoolchildren 
 
H/o, PE and ECG ( expert sports 
cardiologist) 
4 WPW 
3 Long QT 
1 ARVC 
1 Right ventricular outflow tract 
ventricular tachycardia 
 
Further tests in 4% 
Pelliccia et al [43] Cross sectional 4450 athletes of  Italian national teams, 
eligible  
 




Mitral Valve Prolapse(n=3) 
Aortic regurgitation(n=2) 
ARVC(n=1) 
Le et al [44] Cross sectional 653 athletes from 24 sports at Stanford 
sports medicine program 
 
H/o, PE and ECG 
10 % had abnormal ECG for further test 
H/o: History, PE: Physical examination, ECG: electrocardiography, ARVC: arrythmogenic right ventricular cardiomyopathy, HCM: Hypertrophic 
cardiomyopathy, AOCA: Anomalous Origin of Coronary Artery, WPW: Wolf Parkinson White syndrome, SCD: Sudden cardiac death, CVD: 
cardiovascular disease, NPV: negative predictive value, PPV: Positive predictive value 
Table 3: Modified Downs & Black (28) quality index results of all included studies 
Reporting 
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Yes Yes Yes Yes Yes Yes No No 
Corrado 
et al[30] 
Cohort Yes Yes Yes Yes Yes Yes U Yes 
Fuller et 
al[31] 




















Yes Yes Yes Yes Yes Yes Yes No 
Magalski 
et al[36] 




















Yes Yes Yes Yes Yes Yes No Yes 
Steinvil 
et al[41] 










Yes Yes Yes Yes Yes Yes Yes No 




Yes Yes Yes Yes Yes Yes Yes Yes 
Table 3 Continued 















































Yes Yes U Yes No Yes Yes Yes 
Corrado 
et al [30] 
Cohort Yes Yes Yes Yes Yes Yes Yes Yes 
Fuller et 
al [31] 
Cohort Yes Yes Yes Yes U U Yes U 
Pelliccia 
et al [32] 
Cross 
sectional 





Yes Yes Yes Yes No Yes Yes Yes 
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Table 3    Continued 
 Selection bias and power 
Study Study design Q21: Same 
population 
Q22: Participants 
recruited at the 
same time 
Q26: Loss of follow 
up reported? 
Total score / 
19 
 
Maron et al [29] Cross sectional Yes Yes No 14 
Corrado et al [30] Cohort 
 
Yes Yes U 17 
Fuller et al [31] Cohort Yes Yes Yes 15 
Pelliccia et al [32] Cross sectional Yes Yes No 15 
Basso et al [33] Case review Yes Yes No 17 
Baggish et al [34] Cross sectional Yes Yes No 17 
Hevia et al [35] Cross sectional Yes No No 15 
Magalski et al [36] Cohort Yes No U 15 
Bessem et al [37] Cross sectional Yes No No 16 
Sofi et al [38] Cross sectional Yes Yes No 18 
Tanaka et al [39] Cross sectional Yes Yes Yes 14 
Marek et al [40] Cohort study Yes Yes U 16 
Baggish 
et al [34] 
Cross 
sectional 





Yes Yes Yes Yes No Yes Yes Yes 
Magalski 
et al [36] 
Cohort Yes Yes Yes Yes U Yes Yes Yes 
Bessem 
et al [37] 
Cross 
sectional 
Yes Yes Yes Yes Yes U Yes Yes 




Yes Yes Yes Yes Yes Yes Yes Yes 
Tanaka 
et al [39] 
Cross 
sectional 





Yes Yes Yes Yes U Yes Yes Yes 
Steinvil 
et al [41] 
Cohort 
study 
U U U U U No No No 
Wilson 
et al [42] 
Cross 
sectional 
Yes Yes Yes Yes U Yes Yes Yes 
Pelliccia 
et al [43] 
Cross 
sectional 
Yes Yes Yes No U Yes Yes Yes 




Yes Yes Yes Yes U Yes Yes Yes 
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Steinvil et al [41] Cohort study Yes Yes U 8 
Wilson et al [42] Cross sectional Yes Yes No 15 
Pelliccia et al [43] Cross sectional Yes Yes No 15 
Le et al [44] Cross sectional Yes Yes Yes 18 
Score of all questions Yes= 1, No = 0; U: Unable to determine 
 
 
3.2     Methodological quality assessment 
 
All of these contained  type II evidence-population 
based clinical studies and were considered for 
methodological quality assessment using modified Downs 
and Black checklist [32] (Table 3). Recurrent weaknesses 
were related to issues of confounding, blinding 
participants and assessors, adjusting analysis for length of 
follow up, randomization and reporting calculation for 
sample size. 
 
3.3 Studies favouring the addition of 
electrocardiography 
The first mandatory mass cardiac screening in 
children began in Japan in 1973. The screening process 
included a questionnaire and an electrocardiography test 
for all students, regardless of athletic participation. 
Tanaka et al [33] reported the cardiac screening results of 
37,807 young adolescents entering seventh grade. Only 
three sudden deaths occurred during 6 years follow-up; 
one 14-year-old boy had hypertrophic cardiomyopathy 
identified during screening and died while jogging (one 
death out of 9 high risk identified). The remaining two 
students, 13 and 16 year old, died during handball and 
basketball, respectively. Both had a normal 
electrocardiogram, showing the difficulty in detecting the 
rare young athletes at increased risk of sudden death 
during competition even with electrocardiography 
screening. The author concluded that the cardiac 
screening system is effective in identifying high risk 
group and cost-effective (estimated cost of $8,800 per 
year of life saved). The death of the high risk participant 
with diagnosed hypertrophic cardiomyopathy might 
indicate the lack of knowledge of whom to restrict from 
sports participation. Moreover no autopsy was performed; 
thus the cause of sudden death cannot be attributed to 
cardiac causes.  
It has been inferred that exercise serves as a 
trigger for individuals with underlying heart disease and 
that early detection may lead to prevention via sports 
exclusion [34]. However, the evidence for this is scarce. 
One notable exception is the northern Italian experience, 
were in 1982 routine 12-lead ECG screening in athletes 
was initiated, and sudden cardiac death rates in the Veneto 
region of Italy during the next two decades decreased 
from 3.6/100,000 athlete-years to 0.4/100,000 athlete-year 
in 2004 [35]. Of the 42386 screened athletes, 8.9% 
required additional cardiovascular testing. Extrapolating 
the Italian data to other population is questionable; one 
can argue that the study was a population based 
observational report, not a controlled comparison of 
screening versus non-screening in athletes. In addition, the 
event rates included all events, not those that occurred 
only with exertion. In the Veneto region, arrythmogenic 
right ventricular cardiomyopathy is a major cause of 
sudden cardiac death, yet in other countries such as USA 
it is hypertrophic cardiomyopathy. Confounding factors to 
the 89% reduction in sudden cardiac death might be 
related to awareness of the community toward the issue 
and the better use of onsite cardiac resuscitation with 
defibrillator. 
 
Pelliccia et al [36] tested the diagnostic efficacy 
of the Italian preparticipation screening program for 
identifying hypertrophic cardiomyopathy; they performed 
echocardiography on 4450 athletes already eligible to 
participate. They found two cases of hypertrophic 
cadiomyopathy, of which one was diagnosed genetically. 
Normal electrocardiography had a very high negative 
predictive value (99.98%) for excluding hypertrophic 
cardiomyopathy in this 8 years follow-up study. Based on 
this long term experience and the conclusion that 
electrocardiographic screening is ‘life saving’ [37,38] the 
European Society of Cardiology and the Lausanne 
protocols [5,39] include 12-lead ECG in athlete’s cardiac 
screening. 
Recent publications have provided some insight 
on the practicalities of electrocardiographic cardiac 
screening in athletes. Bessem et al [40] included 428 
screening test out of 825 screening performed; following a 
good inclusion/exclusion criteria (age 12-35 and 
excluding subjects with established cardiovascular 
conditions) only 6.3% of electrocardiography required 
further assessment, and electrocardiography had a false-
positive screening outcome of 11%. This slightly higher 
false-positive rate may be partly related to the population 
screened, with 7% of athletes being referred for screening 
because of cardiovascular symptoms. When we look at the 
number of athletes needed to be screened to find a single 
athlete with a cardiovascular disease, a total of 143 
athletes seem acceptable. This study shows that the 
Lausanne recommendations are an effective screening 
tool to detect potentially lethal cardiovascular diseases. 
The Dutch experience showed similar finding to the 
earlier Italian findings.  
 
Hevia et al [41] showed that the rate of abnormal 
electrocardiography is low (6.14%) and only 3.27% 
required additional tests. The value of history and 
examination alone is questionable, with false positive of 
1.2%. This study was a descriptive result of cross 
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sectional study, without providing follow-up data on 
clinical end point. The sample group was a selected 
population of male white athletes, and the results should 
not be extrapolated to other sex or ethnic groups. But  the 
use of well-trained sports physician and cardiologist 
added strength to this study by minimising the false 
positive rate of electrocardiography.   
 
Interestingly Sofi et al [42] examined 30,065 subjects 
and showed that only a small proportion (1.2%) of 
athletes had distinct abnormalities identified on resting 
electrocardiography. Thus, false positives were few. 
Importantly, 153 of the 159 true positives involving 
athletes disqualified from sport with an identified 
cardiovascular disorder would have been missed on 
history and physical examination alone. Thus, adding 
electrocardiography will detect more athletes with silent 
cardiovascular disorders at risk of sudden death. Two 
important issues related to this study; firstly, the cohorts 
age ranged from 5 to 92 years of age (40% >30 years of 
age), thus one cannot compare these results to most 
studies where the cohort were young athletes; secondly 
there was no second line investigation in participants with 
positive screening results making it difficult to interpret 
the real diagnostic power of electrocardiography, as well 
as the important matter of false positive results. 
Wilson et al [43] examined junior athletes and 
physically active schoolchildren. This study was well 
conducted, with subjects representing the sporting 
community and questionnaires needed parent’s 
completion. The use of a detailed medical questionnaire 
improved its sensitivity. Moreover, the rate of further 
investigations was reduced to 4% compared to 8.9% in the 
Italian experience [37], because electrocardiography was 
conducted by UK’s leading sport’s cardiologists. The 
false-positive rate was higher for medical questionnaires 
than for electrocardiography alone in schoolchildren. The 
prevalence of junior athletes diagnosed with a cardiac 
disease was over twice (0.5%) that of schoolchildren 
(0.2%), this supports the recommendation to screen 
selected groups to minimise expenditure and improve 
accuracy of testing. None of the diagnosed athletes were 
symptomatic, confirming that history and examination 
alone are inadequate. Hypertrophic cardiomyopathy the 
commonest cause of sudden cardiac death in young 
athletes [44] was not detected in this study, although 
electrocardiography is abnormal in >90% of patients with 
hypertrophic cardiomyopathy. 
Interestingly new supportive data for the 
effectiveness of adding electrocardiography are coming 
from United States. Baggish et al [45] compared a 
screening protocol with or without electrocardiography, 
and showed that addition of electrocardiography improved 
sensitivity for detecting serious cardiac abnormalities 
from 45.5% to 90.9%, and altered the negative predictive 
value of screening from 98.7% to 99.8%. The false 
positive rate was 16.9%. These findings were similar to 
the work of Magalski et al [46], with electrocardiography 
improving sensitivity of medical questionnaire and 
physical exam from 44.5% to 88.9% and altering the 
negative predictive value from 99.3% to 99.9%. The false 
positive rate were higher in black athletes and might have 
been reduced overall if the examiners where specialised 
cardiologists and used the latest European Society of 
Cardiology electrocardiography criteria [47]. Both studies 
participants had received preparticipation screening at 
college already, thus the study cohort may underrepresent 
the true burden of occult cardiac disease. 
Marek et al [48] examined the feasibility of a large-
scale high school electrocardiography screening program 
(Young Hearts for Life [YH4L]) developed in Chicago, 
USA. This retrospective cohort study examined 32,561 
high school students between 2006 and 2009. It involved 
administrators, cardiologists and community volunteers 
who underwent specialised training and quality review. 
Only 2.5% had abnormal electrocardiography requiring 
further evaluation. These new American findings can have 
great implications for implementing screening and 
preventing cardiac sudden death in USA. 
These studies clearly showed that history and 
physical examination alone are inadequate; 
electrocardiography has an independent added value for 
diagnosing cardiac disease that can lead to sudden cardiac 
death. Apart from the Italian experience, most of the 
studies could not draw definitive conclusions about the 
effect of the different screening strategies on the incidence 
of sudden death in athletes.  
The latest studies have compared the performance 
between history, physical examination, and 
electrocardiography during preparticipation 
cardiovascular screening (Table 4). The combined average 
sensitivity from these studies to identify athletes with at 
risk conditions using history and physical examination is 
12% compared with 88% using electrocardiography. 
 
Table 4 Comparison of history and physical examination Vs ECG in 
screening young athletes 
 
 Positive results requiring 
further test 
Sensitivity to Detect 
Lethal CVD 





2.5% 1.5% 4% 9 0 100% 
Bessem 
et al [37] 
8% 8% 13% 3% 33% 67% 
Hevia et 
al [35] 
1.2% 6.1% 7.4% 2 0 100% 
Baggish 
et al [34] 
6% 16% 20% 3 33% 67% 
Total 4.4% 7.9% 11.1% 17 12% 88% 
H&P: History & Physical Examination 
 
3.4 Studies not favouring the addition of 
electrocardiography  
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Observational data with the inclusion of 
electrocardiography in athletic screening in multiple 
countries have not reproduced the Italian experience. In 
1982 Maron et al [49] examined 501 athletes, 
electrocardiography showed specificity of 27% and high 
false positive of 15%. The conclusion was drawn that 
electrocardiography is poorly sensitive. One can argue 
that the “cardiac outcome” in this study was ill defined; 
they looked for hypertrophic cardiomyopathy, Marfan 
syndrome and cardiovascular disease. The cohort was too 
small to detect rare causes of sudden cardiac death. 
Pelliccia et al [50] examined 1005 athletes; he 
recorded electrocardiography sensitivity of 51%, 
specificity of 61%, positive predictive value of 7%, and 
negative predictive value of 96%. The cohort was 
heterogeneous; the first group underwent routine cardiac 
screening while the second group where specifically 
referred to the center for suspected cardiac conditions.  
Highest incidence of heart disease (15%) was seen in the 
referred group. Thus this data cannot be compared directly 
to other large electrocardiography screening studies; 
moreover one cannot determine what value 
electrocardiography added beyond history and 
examination alone. 
Fuller et al [51] cohort was larger (5615 high 
school athletes); addition of electrocardiography improved 
the sensitivity of screening to 70%, while 
echocardiography increased it to further 80%. 
Electrocardiography had similar specificity to history and 
examination alone, yet more effective screening tool with 
a false positive rate of 2.7 % (2000 athletes had further 
tests). The true incidence of cardiac disease is not known 
in this cohort, because echocardiography was not 
performed in the entire cohort. 
Congenital coronary artery anomalies could be 
missed in the absence of imaging techniques, Basso et al 
[52] examined 2 large registries of Sudden Cardiac Death 
in young athletes in USA and Italy, all of the 27 deaths 
related to Anomalous Origin of Coronary Artery had 
normal electrocardiography, echocardiography and stress 
test. Thus, standard preparticipation evaluation of athletes 
has a limited ability to detect these anomalies. 
The Israeli experience showed neither utility nor 
cost effectiveness, despite the Israeli National Sports Law 
implementation in 1997.Steinvil et al [53] searched two 
newspapers to determine the yearly number of sudden 
cardiac death in Israeli athletes; he showed no difference 
in incidence of sudden cardiac death in athletes before or 
after electrocardiography screening. Reliance on 
newspapers can underestimate sudden cardiac death 
numbers; furthermore, assumptions regarding the number 
of screened athletes were only estimates. This lack of 
solid numbers for both the numerator and denominator 
makes the death rates not reliable. Moreover, it is a 
surprise that results of the Israel screening program were 
completely ignored with no information regarding the 
implementation of the national screening, the number of 
examined athletes, the proportion of disqualified ones, and 
the cardiac abnormalities discovered. In short, no data 
derived from the direct experience of sport physicians 
support the alleged inefficacy of the screening program in 
Israel. 
None of the studies were primarily designed to 
prospectively evaluate electrocardiography in its ability to 
add value to history and physical examination, nor to 
determine the effect of the screening electrocardiography 
on overall cardiac outcome, survival, cost, and impact on 
athletes. The American Heart Association has been 
hesitant to adopt the international public health screening 
strategy for its young athletes [7] although 
electrocardiography screening is now mandatory in some 
professional organisations such as the National Basketball 
Association.  
 
3.5     New 2010 electrocardiography criteria reduces 
false positive rate 
The introduction of the 2010 European Society 
of Cardiology criteria for electrocardiography 
interpretation in athletes improved the false positive rate. 
When Corrado et al [47] applied this new classification to 
the previously reported data from Pelliccia et al [50] on 
1005 highly trained athletes, 292 of the 402 athletes 
previously described as having electrocardiographic 
abnormalities showed either an isolated increase of QRS 
voltage (n = 233) or early repolarization patterns (n = 59). 
Only 11% (n = 110) were classified as ‘‘uncommon and 
training-unrelated’’ according to the new criteria. The 
new electrocardiographic criteria increased the 
electrocardiography specificity by 70%, primarily in the 
important group of athletes who exhibit pure voltage 
criteria for left ventricular hypertrophy and early 
repolarization abnormalities, maintaining sensitivity for 
detection of cardiovascular diseases at risk of sudden 
cardiac death during sports. 
 
Similarly Weiner et al [54] examined the 
performance of the 2010 European Society of Cardiology 
criteria for electrocardiography interpretation in the same 
athletic population previously screened by Baggish et al 
using traditional criteria [45]. Application of the new 
electrocardiographic criteria improved the accuracy of an 
electrocardiographic-inclusive preparticipation screening 
strategy, by improving specificity [i.e. reducing the 
number of participants with false positive 
electrocardiography findings from 83 of 508 (16.3%) to 
49 of 508 (9.6%) and, most importantly, preserving 
sensitivity]. The reduction in the number of abnormal 
electrocardiography was driven by the reclassification of 
participants with isolated QRS voltage criteria for left 
ventricular hypertrophy from abnormal to normal. This 
shows the potential efficacy of the new classification in 
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increasing the specificity of electrocardiography as a part 
of cardiac screening. 
 
It is imperative that only experienced sports 
cardiologist should perform electrocardiography, 
ultimately reducing the likelihood of recording false-
positive or false-negative finding, thus reducing further 
investigation and hence improving the cost-effectiveness 
of this approach. 
 
3.6     Is electrocardiography screening cost-effective? 
 
Few data exist on the cost effectiveness of 
preparticipation cardiac screening in athletes, and these 
are not easily comparable. Wheeler et al [55] assessed the 
costs and survival rates in U.S. athletes who were 
screened with or without 12-lead ECG and estimated that 
electrocardiography resulted in 2.1 life-years saved per 
1000 athletes screened. The cost-effectiveness ratio of the 
screening with electrocardiography was $42 000 per life-
year saved. Fuller et al [56] showed similar results 
supportive of an electrocardiography based screening. It 
can be concluded that electrocardiography based 
screening is more cost-effective than history and physical 
examination alone ($8,800-$44,000 vs. >$84,000 
respectively), with cost estimates per year of life saved 
below $50,000, which is the traditional threshold to 
consider a health intervention as cost-effective. 
 
An Italian cost-effectiveness analysis of 33,375 
athletes using a more conservative approach (10% of 
affected athletes would live an additional 20 years). The 
study estimated the cost per year of life saved at $18,666 
for the Italian model. 
 
The implementation of a national screening 
program to identify silent cardiac disease in healthy young 
athletes cannot be regarded cost-effective in the United 
Kingdom, were health service is already burdened with 
limited resources and finances.  Perhaps further 
development of new even stricter electrocardiography 
criteria for abnormalities will have the potential to further 
decrease the false positive rate and potentially improving 
the cost-effectiveness. 
 
3.7  Issue of sudden cardiac death incidence 
 
Sudden cardiac death is the leading cause of 
death in young athletes. However, the exact incidence of 
sudden cardiac death is unknown, and it is difficult to 
compare studies with different methodology and from 
widely different geographic areas. A prospective Italian 
study showed an annual incidence of 1 in 25,000 young 
competitive athletes per year [34], while early American 
data of sudden cardiac death among high school and 
college athletes has been estimated to be <1 in 100,000 
participant per year [1,57]. Each study differs in the 
methodology of data collection and athletic age group. In 
comparison to the American data, the Italian data included 
older athletes and a higher proportion of men (age range 
12-35 vs. 12-24 years, men 85% vs. 65%). This can 
explain the higher reported incidence of mortality in the 
Italian study. Moreover, the Italian data were 
systematically collected from national registry; on the 
other hand, the American data were based on retrospective 
analysis of media report and insurance claims, which 
underestimate the mortality rate.  
 
Studies with more accurate reporting system 
have found a higher incidence of sudden cardiac death 
than early estimates and quite similar to the Italian data. In 
National Collegiate Athletic Association athletes, the 
overall incidence of sudden cardiac death was 1:43,000 
athletes per year. Higher risk was found in black male 
athletes (1:13,000) and male basketball players (1:7000) 
[2]. Similarly, a recent prospective population based study 
conducted at 11 American and Canadian cities found an 
incidence of sudden cardiac death from cardiovascular 
disease of 1:27 000 in young adults [58]. 
 
3.8  Limitations of the literature review 
 
The access to only two search databases 
(MEDLINE and CINAHL) might have reduced the 
number of yielded searches and hence some articles might 
have not been detected, but a thorough search at 
references reduced this likelihood. The Downs and Black 
‘Quality Index’ used was considered the most relevant 
quality assessment scale for evaluating case control and 
cohort studies. However many of the checklist were 
irrelevant, hence the power of the score was low. Results 
of this quality index should be taken cautiously as it was 
not conducted by independent reviewer. 
 
4  Conclusion 
 
The high false positive rate of 
electrocardiography, low prevalence of cardiac cause of 
sudden death, cost-effectiveness are all debated against 
with new data on high prevalence of sudden cardiac death 
in USA and improved false positive rate when using the 
new 2010 electrocardiography criteria from the European 
Society of Cardiology. The current scientific evidence 
suggests that screening with electrocardiography 
represents best clinical practice to prevent or reduce the 
risk of sudden cardiac death in young athletes. It 
significantly improves the sensitivity of the history and 
physical examination; it has reasonable specificity and 
excellent negative predictive value; and it is inexpensive 
compared to echocardiogram. Future studies must be 
conducted in a large, multicentre, multination, prospective 
trial that is powered to determine how different screening 
options affect the incidence of sudden cardiac death. 
While we await such studies one can recommend a 
targeted screening at certain age group and level of 
competition that will defiantly be a more cost-effective. 
Moreover, secondary prevention of sudden cardiac death 
is crucial with training the pitch side medical personnel on 
cardiac resuscitation and the immediate use of 
defibrillator. 
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